Effects of physical exercise combined with captopril or losartan on left ventricular hypertrophy of hypertensive rats

Clin Exp Hypertens. 2021 Aug 18;43(6):536-549. doi: 10.1080/10641963.2021.1907399. Epub 2021 Apr 18.

Abstract

Background: Left ventricular hypertrophy (LVH) is an endpoint of hypertensive cardiac alterations. Renin-angiotensin-aldosterone system (RAAS) blockers are among the most effective on LVH regression. Physical exercise combined to antihypertensive drug contributes to arterial pressure (AP) control and LVH prevention. We evaluated the effects of physical exercise combined to captopril or losartan during eight weeks for spontaneously hypertensive rats (SHR) on some cardiac parameters.Methods: SHR (n=5-6 per group) were sedentary or trained 5 days a week in treadmill during 8 weeks; and they were treated with daily oral captopril (12.5, 25, or 50mg/kg), losartan (2.5, 5, or 10mg/kg), or vehicle. At the end, it was obtained systolic AP (SAP), electrocardiogram (ECG), and hearts metalloproteinase 2 (MMP-2) activity and histology.Results: Captopril 25 and 50 mg/kg, and losartan 10 mg/kg lowered SAP of sedentary and trained SHR. Losartan 5 mg/kg combined with physical exercise also lowered SAP. Combined with exercise, captopril 50 mg/kg lowered 13.6% of QT interval, 14.2% of QTc interval, and 22.8% of Tpeak-Tend compared to sedentary SHR. Losartan 5 and 10mg/kg lowered QT interval of sedentary and trained SHR. Losartan 2.5, 5 and 10mg/kg combined with physical exercise lowered respectively 25.4%, 24.8%, and 31.8% of MMP-2 activity. Losartan (10mg/kg) combined with exercise reduced cardiomyocyte diameter.Conclusion: These data support the hypothesis of physical exercise combined with RAAS blockers could improve the benefits on hypertensive LVH treatment.

Keywords: Treadmill exercise; cardiac hypertrophy; electrocardiogram; renin-angiotensin system blockers; spontaneous hypertensive rats.

MeSH terms

  • Animals
  • Antihypertensive Agents / pharmacology
  • Antihypertensive Agents / therapeutic use
  • Blood Pressure / drug effects
  • Captopril / pharmacology
  • Hypertension* / drug therapy
  • Hypertrophy, Left Ventricular* / prevention & control
  • Losartan* / pharmacology
  • Matrix Metalloproteinase 2 / pharmacology
  • Rats
  • Rats, Inbred SHR

Substances

  • Antihypertensive Agents
  • Captopril
  • Matrix Metalloproteinase 2
  • Losartan